{"nct_id":"NCT01915758","title":"W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2008-11-21","start_date_type":"ACTUAL","primary_completion_date":"2009-02-20","primary_completion_date_type":"ACTUAL","completion_date":"2009-02-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}